Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

Top Coronary Artery Disease News of 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

TCT 296: Ultrasound-Guided Transfemoral Access for Coronary Procedures: A Pooled Learning Curve Analysis of the FAUST and UNIVERSAL Trials

Presentation TCT 2023

TCT 296: Ultrasound-Guided Transfemoral Access for Coronary Procedures: A Pooled Learning Curve Analysis of the FAUST and UNIVERSAL Trials

Presenter: Sanjit Jolly

October 26, 2023

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

Presentation TCT 2023

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

Presenter: Sanjit Jolly

October 25, 2023

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

Presentation TCT 2023

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

Presenter: Sanjit Jolly

October 25, 2023

Con: Favorable Data Is Lacking on MCS in AMI Cardiogenic Shock (Randomized Data Are Needed)

Presentation TCT 2023

Con: Favorable Data Is Lacking on MCS in AMI Cardiogenic Shock (Randomized Data Are Needed)

Presenter: Sanjit Jolly

October 24, 2023

ACT Outpatient and Inpatient Trials

Podcast TCTMD Talking Points

ACT Outpatient and Inpatient Trials

August 09, 2023

For Complex PCI, Intravascular Imaging Lowers Risk of Target Vessel Failure

News Conference News ACC 2023

For Complex PCI, Intravascular Imaging Lowers Risk of TVF

Michael O'Riordan

March 05, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.